CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 654 enrolled
Drug / intervention
Cataldo Lung Cancer Stigma Scale (Smoking-Related Subscale) +5 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03891602
NCT03891602N/ACompleted
CompareCT.gov

Using a Mixed Methods Approach to Understand Shared Decision-Making in Lung Cancer Screening

Hackensack Meridian Health·observational·Posted Mar 27, 2019·Updated Aug 23, 2024

In Brief

An observational study evaluating Cataldo Lung Cancer Stigma Scale (Smoking-Related Subscale), Patient Trust in the Medical, and 4 other interventions for Smoking and 3 related conditions. Completed, enrolled 654 participants across 1 site.

Detailed Summary

The purpose of this study is to learn about discussion between clinicians and their patients related to lung screening. Survey answers will be collected from both clinicians and their patients.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSmoking, Smoking, Tobacco, Smoking, Cigarette, Lung Cancer
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI), Indiana University, University of North Carolina, Memorial Sloan Kettering Cancer Center, Kaiser Permanente

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedMar 27, 2019
Enrollment StartMar 22, 2019
Primary CompletionJan 10, 2023
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 7.3 years ago

Interventions

Cataldo Lung Cancer Stigma Scale (Smoking-Related Subscale)behavioral

Perceived Smoking-Related Stigma will be measured using the 5-item Cataldo Lung Cancer Stigma Scale (Smoking-Related Subscale). The response scale is 1 = strongly disagree, to 4 = strongly agree, and scores range from 5 to 25 (high stigma). Cronbach's alphas were 0.75 to 0.89 in prior studies.

Patient Trust in the Medicalbehavioral

Medical Mistrust will be measured using the 5-item Patient Trust in the Medical Profession Scale.80 The five-point Likert responses measure the extent to which patients perceive their clinician to be honest, caring more about convenience, thorough and careful, and trusted. The range of scores is 5 to 25 (higher mistrust). Reliability and validity have been well established with a Cronbach"s alpha of 0.84.

Decision Conflict Scale (DCS) - Lung Cancer Screeningbehavioral

The DCS is a 16-item Likert-response item scale that has been modified for the lung cancer screening and smoking cessation contexts. The DCS was developed by O"Connor,74-75 and validated in many health decisions including breast cancer screening with Cronbach"s alphas ranging from 0.78 to 0.81. 74-75 Despite its name, the DCS measures more than decision conflict to encompass personal perceptions of perceived decision-making quality such as feeling the choice is informed, values based, and likely to be implemented as well as expressing satisfaction with the decision. 74-75 The DCS is comprised of items with response options ranging from 1 (strongly disagree) to 5 (strongly agree). The items are summed to total scale score with lower scores reflective of higher decision conflict and higher scores reflective of lower decision conflict.

Shared Decision Making Questionnaire (SDM-Q)- Patientbehavioral

Shared Decision Making Process will be measured from the patient perspective using the 9-item Shared Decision Making Questionnaire (SDM-Q-9),77 which has been validated with a Cronbach"s alpha of 0.94.

Stage of Readiness for Smoking Cessation - Contemplation Ladderbehavioral

Among current smokers

Primary Care Clinicians' Lung Cancer Screening Surveybehavioral

Includes items to assess attitudes, barriers, and knowledge of lung cancer screening guidelines.